Literature DB >> 20025587

Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy.

Sophie Mavrogeni1, Kostas Spargias, Vyron Markussis, Genovefa Kolovou, Eftichia Demerouti, Evangelia Papadopoulou, George Stavridis, Loukas Kaklamanis, Marouso Douskou, Pantelis Constantoulakis, Dennis V Cokkinos.   

Abstract

INTRODUCTION: Myocardial inflammation often coexists with different types of autoimmune diseases. Our aim was to investigate the presence of myocarditis in these patients by Cardiovascular Magnetic Resonance (CMR) and endomyocardial biopsy. PATIENTS-
METHODS: Twenty patients, aged 20-55 yrs with autoimmune diseases and cardiac symptoms (3 with Takayasu's arteritis, 3 with systemic lupus erythematosus, 5 with rheumatoid arthritis, 7 with autoimmune thyroid disease and 2 with systemic sclerosis) and 20 patients with the same autoimmune diseases but without cardiac symptoms (controls) were studied. The presence of myocarditis and LV function were evaluated by CMR. Myocarditis was documented using T2-weighted (T2-W), T1-weighted (T1-W) before and after contrast media injection and late enhanced images. In 10 patients (positive for myocarditis by CMR with either low LVEF or recent increase in troponin), endomyocardial biopsy was also performed. Myocardial specimens were evaluated by histology and polymerase chain reaction techniques (PCR).
RESULTS: Myocarditis was identified in 18/20 patients by CMR. In the T2-W images the signal ratio of myocardium to skeletal muscle was 1.89+/-0.25 (control values 1.57+/-0.13, p<0.05). From the T1-W images the relative myocardial enhancement was 11.31+/-11.18 (control values 3.09+/-0.05, p<0.05). Epicardial late gadolinium enhanced areas were identified in 18/20. In myocardial specimens, histology revealed inflammation in 5/10 (50%) and PCR documented viral or microbial genomes in 8/10 (80%). Positive histology and PCR were in agreement with 50% and 80% of positive CMR examinations, respectively. Herpes virus was identified in 3/10, Adeno in 1/10, Coxsackie B6 in 1/10, echo in 1/10, Parvo-B19 in 3/10, CMV in 1/10 and Chlamydia trachomatis in 8/10.
CONCLUSIONS: Myocardial inflammation is a common finding in patients with autoimmune diseases and cardiac symptoms. The diagnosis can be confirmed by CMR, which is a noninvasive and reliable tool for the investigation of these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025587     DOI: 10.2174/1871528110908050390

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  15 in total

1.  Role of cardiovascular imaging in systemic autoimmune diseases.

Authors:  Simona Sitia; Luigi Gianturco; Livio Tomasoni; Maurizio Turiel
Journal:  World J Cardiol       Date:  2010-08-26

Review 2.  Imaging modalities for the diagnosis of pulmonary hypertension in systemic sclerosis.

Authors:  Theodoros Dimitroulas; Sophie Mavrogeni; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2012-02-07       Impact factor: 20.543

Review 3.  Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps.

Authors:  Thomas Zegkos; George Kitas; Theodoros Dimitroulas
Journal:  Ther Adv Musculoskelet Dis       Date:  2016-04-30       Impact factor: 5.346

Review 4.  "Save the Last Dance" for Cardiovascular Magnetic Resonance.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; Genovefa Kolovou
Journal:  Eur Cardiol       Date:  2018-12

Review 5.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

6.  A case of acute myocarditis associated with Chlamydia trachomatis infection: role of cardiac MRI in the clinical management.

Authors:  S Dellegrottaglie; G Russo; M Damiano; P Pagliano; L Ferrara; C De Simone; P Guarini
Journal:  Infection       Date:  2014-05-31       Impact factor: 3.553

Review 7.  "How many times must a man look up before he can really see the sky?" Rheumatic cardiovascular disease in the era of multimodality imaging.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; David Heutemann; Kees van Wijk; Hans J Reiber; Genovefa Kolovou
Journal:  World J Methodol       Date:  2015-09-26

Review 8.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease.

Authors:  Sophie Mavrogeni; George Papadopoulos; Tarique Hussain; Amedeo Chiribiri; Rene Botnar; Gerald F Greil
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-15       Impact factor: 2.357

Review 9.  Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

Authors:  Karen G Ordovas; Lauren A Baldassarre; Chiara Bucciarelli-Ducci; James Carr; Juliano Lara Fernandes; Vanessa M Ferreira; Luba Frank; Sophie Mavrogeni; Ntobeko Ntusi; Ellen Ostenfeld; Purvi Parwani; Alessia Pepe; Subha V Raman; Hajime Sakuma; Jeanette Schulz-Menger; Lilia M Sierra-Galan; Anne Marie Valente; Monvadi B Srichai
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

Review 10.  Imaging assessment of cardiovascular disease in systemic lupus erythematosus.

Authors:  Sara C Croca; Anisur Rahman
Journal:  Clin Dev Immunol       Date:  2011-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.